• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒产生细胞释放的包含 EBV 被膜蛋白 BGLF2 的外泌体促进了新的感染。

Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection.

机构信息

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

PRESTO, Japan Science and Technology Agency (JST), Kawaguchi, Japan.

出版信息

Cell Commun Signal. 2022 Jun 21;20(1):95. doi: 10.1186/s12964-022-00902-7.

DOI:10.1186/s12964-022-00902-7
PMID:35729616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9210680/
Abstract

BACKGROUND

Viruses must adapt to the environment of their host cells to establish infection and persist. Diverse mammalian cells, including virus-infected cells, release extracellular vesicles such as exosomes containing proteins and miRNAs, and use these vesicles to mediate intercellular communication. However, the roles of exosomes in viral infection remain unclear.

RESULTS

We screened viral proteins to identify those responsible for the exosome-mediated enhancement of Epstein-Barr virus (EBV) infection. We identified BGLF2 protein encapsulated in exosomes, which were released by EBV-infected cells. BGLF2 protein is a tegument protein that exists in the space between the envelope and nucleocapsid, and it is released into the cytoplasm shortly after infection. BGLF2 protein-containing exosomes enhanced viral gene expression and repressed innate immunity, thereby supporting the EBV infection.

CONCLUSIONS

The EBV tegument protein BGLF2 is encapsulated in exosomes and released by infected cells to facilitate the establishment of EBV infection. These findings suggest that tegument proteins support viral infection not only between the envelope and nucleocapsid, as well as in extraviral particles such as exosomes. Video abstract.

摘要

背景

病毒必须适应宿主细胞的环境才能建立感染并持续存在。包括病毒感染细胞在内的各种哺乳动物细胞会释放含有蛋白质和 miRNA 的细胞外囊泡(如外泌体),并利用这些囊泡来介导细胞间的通讯。然而,外泌体在病毒感染中的作用尚不清楚。

结果

我们筛选了病毒蛋白,以鉴定那些负责外泌体介导增强 Epstein-Barr 病毒(EBV)感染的蛋白。我们鉴定出了 EBV 感染细胞释放的囊泡中的 BGLF2 蛋白。BGLF2 蛋白是一种位于包膜和核衣壳之间的被膜蛋白,在感染后不久就会被释放到细胞质中。含有 BGLF2 蛋白的外泌体增强了病毒基因的表达,并抑制了先天免疫,从而支持 EBV 的感染。

结论

EBV 被膜蛋白 BGLF2 被包裹在囊泡中,并由感染细胞释放,以促进 EBV 感染的建立。这些发现表明,被膜蛋白不仅在包膜和核衣壳之间,而且在病毒外粒子(如外泌体)中支持病毒感染。视频摘要。

相似文献

1
Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection.病毒产生细胞释放的包含 EBV 被膜蛋白 BGLF2 的外泌体促进了新的感染。
Cell Commun Signal. 2022 Jun 21;20(1):95. doi: 10.1186/s12964-022-00902-7.
2
Suppression of JAK-STAT Signaling by Epstein-Barr Virus Tegument Protein BGLF2 through Recruitment of SHP1 Phosphatase and Promotion of STAT2 Degradation.EB 病毒被膜蛋白 BGLF2 通过募集 SH2 结构域蛋白磷酸酶 1 和促进 STAT2 降解抑制 JAK-STAT 信号通路。
J Virol. 2021 Sep 27;95(20):e0102721. doi: 10.1128/JVI.01027-21. Epub 2021 Jul 28.
3
Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.EBV 衣壳蛋白 BGLF2 抑制 I 型干扰素信号通路以促进 EBV 再激活。
J Virol. 2020 May 18;94(11). doi: 10.1128/JVI.00258-20.
4
Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.爱泼斯坦-巴尔病毒(EBV)被膜蛋白BGLF2通过激活p38丝裂原活化蛋白激酶促进EBV再激活。
J Virol. 2015 Nov 11;90(2):1129-38. doi: 10.1128/JVI.01410-15. Print 2016 Jan 15.
5
BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon Infection.BGLF2 通过感染后激活 AP-1 来增加 Epstein-Barr 病毒的感染力。
mSphere. 2018 Apr 25;3(2). doi: 10.1128/mSphere.00138-18.
6
Epstein-Barr virus tegument protein BGLF2 inhibits NF-κB activity by preventing p65 Ser536 phosphorylation.EB 病毒被膜蛋白 BGLF2 通过阻止 p65 Ser536 磷酸化抑制 NF-κB 活性。
FASEB J. 2019 Sep;33(9):10563-10576. doi: 10.1096/fj.201901196RR. Epub 2019 Jul 23.
7
Epstein-Barr Virus BGLF2 commandeers RISC to interfere with cellular miRNA function. Epstein-Barr 病毒 BGLF2 操纵 RISC 来干扰细胞 miRNA 功能。
PLoS Pathog. 2022 Jan 10;18(1):e1010235. doi: 10.1371/journal.ppat.1010235. eCollection 2022 Jan.
8
Modulation of B-cell exosome proteins by gamma herpesvirus infection.γ 疱疹病毒感染对 B 细胞外泌体蛋白的调节作用。
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2925-33. doi: 10.1073/pnas.1303906110. Epub 2013 Jul 1.
9
Molecular Characterization of the Epstein-Barr Virus Gene, its Expression, and Subcellular Localization.爱泼斯坦-巴尔病毒基因的分子特征、表达及其亚细胞定位
Iran J Biotechnol. 2018 May 15;16(2):e1610. doi: 10.21859/ijb.1610. eCollection 2018 May.
10
Tegument proteins of Epstein-Barr virus: Diverse functions, complex networks, and oncogenesis.EB 病毒的被膜蛋白:多样的功能、复杂的网络和致癌作用。
Tumour Virus Res. 2023 Jun;15:200260. doi: 10.1016/j.tvr.2023.200260. Epub 2023 May 9.

引用本文的文献

1
On the road: extracellular vesicles in intercellular communication.在路上:细胞间通讯中的细胞外囊泡
Cell Commun Signal. 2025 Feb 18;23(1):95. doi: 10.1186/s12964-024-01999-8.
2
Viral Membrane-Targeting Amphipathic Helical Peptide-Based Fluorogenic Probes for the Analysis of Infectious Titers of Enveloped Viruses.用于分析包膜病毒感染滴度的基于病毒膜靶向两亲性螺旋肽的荧光探针
Anal Chem. 2025 Mar 18;97(10):5480-5487. doi: 10.1021/acs.analchem.4c04852. Epub 2025 Jan 22.
3
A State-of-the-Art Review on the Recent Advances in Exosomes in Oncogenic Virus.

本文引用的文献

1
A STING inhibitor suppresses EBV-induced B cell transformation and lymphomagenesis.一种 STING 抑制剂抑制 EBV 诱导的 B 细胞转化和淋巴瘤发生。
Cancer Sci. 2021 Dec;112(12):5088-5099. doi: 10.1111/cas.15152. Epub 2021 Oct 11.
2
Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection.B细胞感染期间,流产性裂解感染介导的爱泼斯坦-巴尔病毒潜伏建立的直接证据。
Front Microbiol. 2021 Jan 21;11:575255. doi: 10.3389/fmicb.2020.575255. eCollection 2020.
3
PPM1G restricts innate immune signaling mediated by STING and MAVS and is hijacked by KSHV for immune evasion.
关于致癌病毒中外泌体最新进展的综述
Health Sci Rep. 2024 Nov 18;7(11):e70196. doi: 10.1002/hsr2.70196. eCollection 2024 Nov.
4
Characterisation of extracellular vesicles in baculovirus infection of cells.杆状病毒感染细胞过程中细胞外囊泡的表征
J Extracell Biol. 2024 Jun 28;3(7):e163. doi: 10.1002/jex2.163. eCollection 2024 Jul.
5
Exosome-Mediated Antigen Delivery: Unveiling Novel Strategies in Viral Infection Control and Vaccine Design.外泌体介导的抗原递送:揭示病毒感染控制和疫苗设计中的新策略。
Vaccines (Basel). 2024 Mar 7;12(3):280. doi: 10.3390/vaccines12030280.
6
Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulation.EB 病毒裂解基因 BNRF1 通过上调 IFI27 促进 B 细胞淋巴瘤发生。
PLoS Pathog. 2024 Feb 1;20(2):e1011954. doi: 10.1371/journal.ppat.1011954. eCollection 2024 Feb.
7
SuPAR mediates viral response proteinuria by rapidly changing podocyte function.suPAR 通过快速改变足细胞功能来介导病毒反应性蛋白尿。
Nat Commun. 2023 Jul 21;14(1):4414. doi: 10.1038/s41467-023-40165-5.
8
Advances in Therapeutic Applications of Extracellular Vesicles.细胞外囊泡治疗应用的新进展。
Int J Nanomedicine. 2023 Jun 16;18:3285-3307. doi: 10.2147/IJN.S409588. eCollection 2023.
9
Epstein-Barr Virus BBLF1 Mediates Secretory Vesicle Transport to Facilitate Mature Virion Release.EB 病毒 BBLF1 介导分泌小泡运输以促进成熟病毒粒子的释放。
J Virol. 2023 Jun 29;97(6):e0043723. doi: 10.1128/jvi.00437-23. Epub 2023 May 17.
10
EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies.EBV脱氧尿苷三磷酸酶:EBV相关恶性肿瘤中炎症和肿瘤微环境的新型调节因子
Cancers (Basel). 2023 Jan 30;15(3):855. doi: 10.3390/cancers15030855.
PPM1G 限制由 STING 和 MAVS 介导的先天免疫信号转导,并且被 KSHV 劫持用于免疫逃避。
Sci Adv. 2020 Nov 20;6(47). doi: 10.1126/sciadv.abd0276. Print 2020 Nov.
4
Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.EBV 衣壳蛋白 BGLF2 抑制 I 型干扰素信号通路以促进 EBV 再激活。
J Virol. 2020 May 18;94(11). doi: 10.1128/JVI.00258-20.
5
Decoy exosomes provide protection against bacterial toxins.诱饵外泌体提供针对细菌毒素的保护。
Nature. 2020 Mar;579(7798):260-264. doi: 10.1038/s41586-020-2066-6. Epub 2020 Mar 4.
6
Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection.爱泼斯坦-巴尔病毒在感染的潜伏前期即刻重编程人类 B 淋巴细胞。
Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):16046-16055. doi: 10.1073/pnas.1901314116. Epub 2019 Jul 24.
7
Epstein-Barr virus tegument protein BGLF2 inhibits NF-κB activity by preventing p65 Ser536 phosphorylation.EB 病毒被膜蛋白 BGLF2 通过阻止 p65 Ser536 磷酸化抑制 NF-κB 活性。
FASEB J. 2019 Sep;33(9):10563-10576. doi: 10.1096/fj.201901196RR. Epub 2019 Jul 23.
8
Decoy exosomes as a novel biologic reagent to antagonize inflammation.作为一种新型生物试剂的诱饵外泌体拮抗炎症。
Int J Nanomedicine. 2019 May 9;14:3413-3425. doi: 10.2147/IJN.S196975. eCollection 2019.
9
RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.原发性 B 淋巴细胞感染 EBV 过程中基因表达的 RNA 测序分析。
J Virol. 2019 Jun 14;93(13). doi: 10.1128/JVI.00226-19. Print 2019 Jul 1.
10
Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications.比较不同方法提取培养上清液中外泌体的产量、纯度和下游应用效果。
Sci Rep. 2019 Mar 29;9(1):5335. doi: 10.1038/s41598-019-41800-2.